Contraceptive Pills and Retinal Vascularization
Completed
- Conditions
- Combined Oral Contraceptives Intake
- Interventions
- Diagnostic Test: OCT-A (optical coherence tomography)
- Registration Number
- NCT03964636
- Lead Sponsor
- Fondation Ophtalmologique Adolphe de Rothschild
- Brief Summary
The main hypothesis is the taking of combined 1st and 2nd generation or 3rd and 4th generation oral contraceptives is associated with a change in retinal micro-vascularization compared to the absence of combined oral contraceptive intake.
Women of childbearing age will be recruited during their ophthalmologic consultation at the Rothschild Foundation, an OCT-A will be realized and data relating to their medical and ophthalmologic history and their oestro-progestative contraceptive intake will be collected.
The objective is to find an association between retinal vascular density and combined oral contraceptives intake.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 51
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description 3rd/4th generation combined oral contraceptives intake OCT-A (optical coherence tomography) - combined 1st/2nd generation oral contraceptives intake OCT-A (optical coherence tomography) - no contraceptive intake OCT-A (optical coherence tomography) -
- Primary Outcome Measures
Name Time Method Density of retinal vascular Plexus (quantitative variable expressed as a percentage) using OCT-A. At the inclusion consultation
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Fondation A de Rothschild
🇫🇷Paris, France